Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kolotilin, Igor ^a   Kaldis, Angelo ^a   Devriendt, Bert ^b   Joensuu, Jussi ^c   Cox, Eric ^b   Menassa, Rima ^a  

^a AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^b GHENT UNIVERSITY   (Belgium)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

F4 RECEPTOR; PEPTIDE VACCINE; RECEPTOR; RECOMBINANT FAEG PROTEIN VACCINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BACTERIUM ADHERENCE; BIOMASS; CHLOROPLAST; CONTROLLED STUDY; DIARRHEA; DRUG DEGRADATION; DRUG RECEPTOR BINDING; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEASIBILITY STUDY; FIMBRIA; GENE DELETION; GENETIC COMPLEMENTATION; GENETIC ENGINEERING; IN VITRO STUDY; INTESTINE BRUSH BORDER; INTESTINE VILLUS; NONHUMAN; PHENOTYPE; PLANT LEAF; POSTWEANING DIARRHEA; PROTEIN AGGREGATION; PROTEIN EXPRESSION; SWINE; TRANSGENIC PLANT; TRANSPLASTOMIC TOBACCO; VACCINE PRODUCTION; WILD TYPE;

ADHESINS, ESCHERICHIA COLI; ANIMALS; BACTERIAL ADHESION; BIOMASS; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; GASTROINTESTINAL TRACT; MICROVILLI; PHENOTYPE; PLANTS, GENETICALLY MODIFIED; PLASTIDS; PROTEIN STABILITY; RECOMBINANT PROTEINS; SWINE; SWINE DISEASES; TOBACCO; TRANSFORMATION, GENETIC; VACCINES, SUBUNIT; WEANING;

ESCHERICHIA COLI; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM; SUS;

EID: 84864565209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042405     Document Type: Article

References (92)

1. Fairbrother JM, Nadeau E, Gyles CL, ((2005)) Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev 6: 17-39.
2. Hampson DJ (1994) Postweaning Escherichia coli diarrhoea in pigs. In: Gyles CL, editor. Escherichia coli in domestic animals and humans. Wallingford: CAB International. 171-191.
3. Bertschinger HU, Fairbrother JM (1999) Escherichia coli infections. In: Straw BE, D'Allaire S, Mengeling WL, Taylor DJ, editors. Diseases of Swine, 8th Edition. Iowa: Iowa State University Press. 431-454.
4. Ciosek D, Truszczynski M, Jagodzinski M, ((1983)) The effectiveness of inactivated vaccines applied parenterally to sows to control Escherichia coli diarrhea in piglets in an industrial fattening farm. Comp Immunol Microbiol Infect Dis 6: 313-319.
5. Van den Broeck W, Cox E, Goddeeris BM, ((1999)) Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect Immun 67: 520-526.
6. Mol O, Oudega B, ((1996)) Molecular and structural aspects of fimbriae biosynthesis and assembly in Escherichia coli. FEMS Microbiol Rev 19: 25-52.
7. Van den Broeck W, Cox E, Oudega B, Goddeeris BM, ((2000)) The F4 fimbrial antigen of Escherichia coli and its receptors. Vet Microbiol 71: 223-244.
8. Van Molle I, Moonens K, Garcia-Pino A, Buts L, De Kerpel M, et al. ((2009)) Structural and thermodynamic characterization of pre- and postpolymerization states in the F4 fimbrial subunit FaeG. J Mol Biol 394: 957-967.
9. Verdonck F, Cox E, Schepers E, Imberechts H, Joensuu J, et al. ((2004)) Conserved regions in the sequence of the F4 (K88) fimbrial adhesin FaeG suggest a donor strand mechanism in F4 assembly. Vet Microbiol 102: 215-225.
10. Gaastra W, Klemm P, Graaf FKd, ((1983)) The nucleotide sequence of the K88ad protein subunit of porcine enterotoxigenic Escherichia coli. FEMS Microbiol Lett 18: 177-183.
11. Guinee PA, Jansen WH, ((1979)) Behavior of Escherichia coli K antigens K88ab, K88ac, and K88ad in immunoelectrophoresis, double diffusion, and hemagglutination. Infect Immun 23: 700-705.
12. Josephsen J, Hansen F, Graaf FKd, Gaastra W, ((1984)) The nucleotide sequence of the protein subunit of the K88ac fimbriae of porcine enterotoxigenic Escherichia coli. FEMS Microbiol Lett 25: 301-306.
13. Klemm P, ((1981)) The complete amino-acid sequence of the K88 antigen, a fimbrial protein from Escherichia coli. Eur J Biochem 117: 617-627.
14. Orskov I, Orskov F, Sojka WJ, Wittig W, ((1964)) K Antigens K88ab(L) and K88ac(L) in E. Coli. A New O Antigen: 0147 and a New K Antigen: K89(B). Acta Pathol Microbiol Scand 62: 439-447.
15. Caloca MJ, Suarez S, ((2006)) Adhesion of Escherichia coli K88ab fimbriae to porcine enterocytes: effect on enzymatic activities of the brush border, and cyclic AMP and GMP levels. Comp Immunol Microbiol Infect Dis 29: 225-231.
16. Caloca MJ, Suarez S, ((2007)) Two specific sites for binding of K88ab Escherichia coli fimbriae to porcine intestinal brush border membranes. Comp Immunol Microbiol Infect Dis 30: 187-195.
17. Jones GW, Rutter JM, ((1972)) Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets. Infect Immun 6: 918-927.
18. Rasschaert K, Verdonck F, Goddeeris BM, Duchateau L, Cox E, ((2007)) Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection. Vet Microbiol 123: 249-253.
19. Bakker D, Willemsen PT, Simons LH, van Zijderveld FG, de Graaf FK, ((1992)) Characterization of the antigenic and adhesive properties of FaeG, the major subunit of K88 fimbriae. Mol Microbiol 6: 247-255.
20. Joensuu JJ, Kotiaho M, Teeri TH, Valmu L, Nuutila AM, et al. ((2006)) Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETEC-neutralizing antibodies in mice. Transgenic Res 15: 359-373.
21. Joensuu JJ, Verdonck F, Ehrstrom A, Peltola M, Siljander-Rasi H, et al. ((2006)) F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets. Vaccine 24: 2387-2394.
22. Melkebeek V, Verdonck F, Goddeeris BM, Cox E, ((2007)) Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine. Vet Immunol Immunopathol 116: 199-214.
23. Yahong H, Liang W, Pan A, Zhou Z, Wang Q, et al. ((2006)) Protective immune response of bacterially-derived recombinant FaeG in piglets. J Microbiol 44: 548-555.
24. Verdonck F, Cox E, Van der Stede Y, Goddeeris BM, ((2004)) Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine 22: 4291-4299.
25. Huang Y, Liang W, Pan A, Zhou Z, Huang C, et al. ((2003)) Production of FaeG, the major subunit of K88 fimbriae, in transgenic tobacco plants and its immunogenicity in mice. Infect Immun 71: 5436-5439.
26. Joensuu JJ, Kotiaho M, Riipi T, Snoeck V, Palva ET, et al. ((2004)) Fimbrial subunit protein FaeG expressed in transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia coli to porcine enterocytes. Transgenic Res 13: 295-298.
27. Shen H, Qian B, Chen W, Liu Z, Yang L, et al. ((2010)) Immunogenicity of recombinant F4 (K88) fimbrial adhesin FaeG expressed in tobacco chloroplast. Acta Biochim Biophys Sin (Shanghai) 42: 558-567.
28. Van Molle I, Joensuu JJ, Buts L, Panjikar S, Kotiaho M, et al. ((2007)) Chloroplasts assemble the major subunit FaeG of Escherichia coli F4 (K88) fimbriae to strand-swapped dimers. J Mol Biol 368: 791-799.
29. Sala F, Manuela Rigano M, Barbante A, Basso B, Walmsley AM, et al. ((2003)) Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 21: 803-808.
30. Ma JK, Drake PM, Christou P, ((2003)) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4: 794-805.
31. Ma JK, Barros E, Bock R, Christou P, Dale PJ, et al. ((2005)) Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6: 593-599.
32. Rice J, Ainley WM, Shewen P, ((2005)) Plant-made vaccines: biotechnology and immunology in animal health. Anim Health Res Rev 6: 199-209.
33. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM, ((2004)) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7: 152-158.
34. Ahmad A, Pereira EO, Conley AJ, Richman AS, Menassa R, ((2010)) Green biofactories: recombinant protein production in plants. Recent Pat Biotechnol 4: 242-259.
35. De Cosa B, Moar W, Lee SB, Miller M, Daniell H, ((2001)) Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol 19: 71-74.
36. Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, et al. ((2003)) Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res 31: 1174-1179.
37. Molina A, Hervas-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi J, ((2004)) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol J 2: 141-153.
38. Zhou F, Badillo-Corona JA, Karcher D, Gonzalez-Rabade N, Piepenburg K, et al. ((2008)) High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 6: 897-913.
39. Oey M, Lohse M, Kreikemeyer B, Bock R, ((2009)) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant Journal 57: 436-445.
40. Maliga P, ((2003)) Progress towards commercialization of plastid transformation technology. Trends Biotechnol 21: 20-28.
41. Bock R, ((2007)) Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Curr Opin Biotechnol 18: 100-106.
42. Lossl AG, Waheed MT, ((2011)) Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. Plant Biotechnol J 9: 527-539.
43. Clarke JL, Daniell H, ((2011)) Plastid biotechnology for crop production: present status and future perspectives. Plant Mol Biol 76: 211-220.
44. Ruf S, Karcher D, Bock R, ((2007)) Determining the transgene containment level provided by chloroplast transformation. Proc Natl Acad Sci USA 104: 6998-7002.
45. Svab Z, Maliga P, ((2007)) Exceptional transmission of plastids and mitochondria from the transplastomic pollen parent and its impact on transgene containment. Proc Natl Acad Sci USA 104: 7003-7008.
46. Sriraman R, Bardor M, Sack M, Vaquero C, Faye L, et al. ((2004)) Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues. Plant Biotechnol J 2: 279-287.
47. Daniell H, ((2006)) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 1: 1071-1079.
48. Daniell H, Chebolu S, Kumar S, Singleton M, Falconer R, ((2005)) Chloroplast-derived vaccine antigens and other therapeutic proteins. Vaccine 23: 1779-1783.
49. Bock R, Warzecha H, ((2010)) Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol 28: 246-252.
50. Kapila J, De Rycke R, Van Montagu M, Angenon G, ((1997)) An Agrobacterium-mediated transient gene expression system for intact leaves. Plant Science 122: 101-108.
51. Voinnet O, Rivas S, Mestre P, Baulcombe D, ((2003)) An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant Journal 33: 949-956.
52. Joensuu JJ, Conley AJ, Lienemann M, Brandle JE, Linder MB, et al. ((2010)) Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana. Plant Physiol 152: 622-633.
53. Lee MY, Zhou Y, Lung RW, Chye ML, Yip WK, et al. ((2006)) Expression of viral capsid protein antigen against Epstein-Barr virus in plastids of Nicotiana tabacum cv. SR1. Biotechnol Bioeng 94: 1129-1137.
54. Ruhlman T, Verma D, Samson N, Daniell H, ((2010)) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol 152: 2088-2104.
55. Nadai M, Bally J, Vitel M, Job C, Tissot G, et al. ((2009)) High-level expression of active human alpha1-antitrypsin in transgenic tobacco chloroplasts. Transgenic Res 18: 173-183.
56. Zhou F, Karcher D, Bock R, ((2007)) Identification of a plastid intercistronic expression element (IEE) facilitating the expression of stable translatable monocistronic mRNAs from operons. Plant Journal 52: 961-972.
57. Vera A, Sugiura M, ((1995)) Chloroplast rRNA transcription from structurally different tandem promoters: an additional novel-type promoter. Curr Genet 27: 280-284.
58. Conley AJ, Zhu H, Le LC, Jevnikar AM, Lee BH, et al. ((2011)) Recombinant protein production in a variety of Nicotiana hosts: a comparative analysis. Plant Biotechnol J 9: 434-444.
59. Menassa R, Nguyen V, Jevnikar A, Brandle J, ((2001)) A self-contained system for the field production of plant recombinant interleukin-10. Mol Breed 8: 177-185.
60. Arlen PA, Falconer R, Cherukumilli S, Cole A, Cole AM, et al. ((2007)) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol J 5: 511-525.
61. McCabe MS, Klaas M, Gonzalez-Rabade N, Poage M, Badillo-Corona JA, et al. ((2008)) Plastid transformation of high-biomass tobacco variety Maryland Mammoth for production of human immunodeficiency virus type 1 (HIV-1) p24 antigen. Plant Biotechnol J 6: 914-929.
62. Yu LX, Gray BN, Rutzke CJ, Walker LP, Wilson DB, et al. ((2007)) Expression of thermostable microbial cellulases in the chloroplasts of nicotine-free tobacco. J Biotechnol 131: 362-369.
63. Matoba N, Davis KR, Palmer KE, ((2011)) Recombinant protein expression in Nicotiana. Methods Mol Biol 701: 199-219.
64. Daniell H, Lee SB, Panchal T, Wiebe PO, ((2001)) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311: 1001-1009.
65. DeGray G, Rajasekaran K, Smith F, Sanford J, Daniell H, ((2001)) Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiol 127: 852-862.
66. Kota M, Daniell H, Varma S, Garczynski SF, Gould F, et al. ((1999)) Overexpression of the Bacillus thuringiensis (Bt) Cry2Aa2 protein in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects. Proc Natl Acad Sci USA 96: 1840-1845.
67. Drechsel O, Bock R, ((2011)) Selection of Shine-Dalgarno sequences in plastids. Nucleic Acids Res 39: 1427-1438.
68. Fernandez-San Millan A, Mingo-Castel A, Miller M, Daniell H, ((2003)) A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol J 1: 71-79.
69. Eibl C, Zou Z, Beck a, Kim M, Mullet J, et al. ((1999)) In vivo analysis of plastid psbA, rbcL and rpl32 UTR elements by chloroplast transformation: tobacco plastid gene expression is controlled by modulation of transcript levels and translation efficiency. Plant Journal 19: 333-345.
70. Staub JM, Maliga P, ((1993)) Accumulation of D1 polypeptide in tobacco plastids is regulated via the untranslated region of the psbA mRNA. EMBO J 12: 601-606.
71. Staub JM, Maliga P, ((1994)) Translation of psbA mRNA is regulated by light via the 5′-untranslated region in tobacco plastids. Plant Journal 6: 547-553.
72. Farran I, Rio-Manterola F, Iniguez M, Garate S, Prieto J, et al. ((2008)) High-density seedling expression system for the production of bioactive human cardiotrophin-1, a potential therapeutic cytokine, in transgenic tobacco chloroplasts. Plant Biotechnol J 6: 516-527.
73. Trebitsh T, Levitan A, Sofer A, Danon A, ((2000)) Translation of chloroplast psbA mRNA is modulated in the light by counteracting oxidizing and reducing activities. Mol Cell Biol 20: 1116-1123.
74. Wirth S, Segretin ME, Mentaberry A, Bravo-Almonacid F, ((2006)) Accumulation of hEGF and hEGF-fusion proteins in chloroplast-transformed tobacco plants is higher in the dark than in the light. J Biotechnol 125: 159-172.
75. McGhee JR, Lamm ML, Strober W (1999) Mucosal immune responses: An overview. In: Orga PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, et al., editors. editors. Mucosal Immunology, 2nd Edition. San Diego: Academic Press. 485-506.
76. Snoeck V, Huyghebaert N, Cox E, Vermeire A, Saunders J, et al. ((2004)) Gastrointestinal transit time of nondisintegrating radio-opaque pellets in suckling and recently weaned piglets. J Control Release 94: 143-153.
77. Merchant HA, McConnell EL, Liu F, Ramaswamy C, Kulkarni RP, et al. ((2011)) Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. European Journal of Pharmaceutical Sciences 42: 3-10.
78. Russell TL, Berardi RR, Barnett JL, Dermentzoglou LC, Jarvenpaa KM, et al. ((1993)) Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm Res 10: 187-196.
79. Calinescu C, Nadeau E, Mulhbacher J, Fairbrother JM, Mateescu MA, ((2007)) Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation. Int J Pharm 343: 18-25.
80. Verdonck F, Joensuu JJ, Stuyven E, De Meyer J, Muilu M, et al. ((2008)) The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization. Vaccine 26: 5728-5735.
81. Van den Broeck W, Cox E, Goddeeris BM, ((1999)) Receptor-specific binding of purified F4 to isolated villi. Vet Microbiol 68: 255-263.
82. Van den Broeck W, Bouchaut H, Cox E, Goddeeris BM, ((2002)) F4 receptor-independent priming of the systemic immune system of pigs by low oral doses of F4 fimbriae. Vet Immunol Immunopathol 85: 171-178.
83. Menassa R, Du C, Yin ZQ, Ma S, Poussier P, et al. ((2007)) Therapeutic effectiveness of orally administered transgenic low-alkaloid tobacco expressing human interleukin-10 in a mouse model of colitis. Plant Biotechnol J 5: 50-59.
84. Harris LJ, Gleddie SC, ((2001)) A modified Rpl3 gene from rice confers tolerance of the Fusarium graminearum mycotoxin deoxynivalenol to transgenic tobacco. Physiol Mol Plant Pathol 58: 173-181.
85. Svab Z, Hajdukiewicz P, Maliga P, ((1990)) Stable transformation of plastids in higher plants. Proc Natl Acad Sci USA 87: 8526-8530.
86. Verma D, Samson NP, Koya V, Daniell H, ((2008)) A protocol for expression of foreign genes in chloroplasts. Nat Protocols 3: 739-758.
87. Bradford MM, ((1976)) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
88. The United States Pharmacopeia (1990) Gastric Fluid, Simulated, TS. USP XXII, N-F XVII. Rockville, MD: United States Pharmacopeial Convention, Inc.
89. The United States Pharmacopeia (2011) Gastric Fluid, Simulated, TS. USP 34, NF 29, V. 1. Rockville, MD: United States Pharmacopeial Convention, Inc. 968.
90. The United States Pharmacopeia (2011) Pancreatin. USP 34, NF 29, V. 3. Rockville, MD: United States Pharmacopeial Convention, Inc. 3803-3805.
91. The United States Pharmacopeia (2011) Intestinal Fluid, Simulated, TS. USP 34, NF 29, V. 1. Rockville, MD: United States Pharmacopeial Convention, Inc. 969.
92. Cox E, Houvenaghel A, ((1993)) Comparison of the in vitro adhesion of K88, K99, F41 and P987 positive Escherichia coli to intestinal villi of 4- to 5-week-old pigs. Vet Microbiol 34: 7-18.